DELRAY BEACH, Fla., Jan. 27, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Proteomics Market is projected to grow from about USD 36.32 billion in 2025 to USD 65.78 billion by 2030, at a CAGR of 12.6%.
Browse 1000 market data Tables and 55 Figures spread through 800 Pages and in-depth TOC on 'Proteomics Market- Global Forecast to 2030'
Proteomics Market Size & Forecast:
- Market Size Available for Years: 2024-2030
- 2025 Market Size: USD 36.32 billion
- 2030 Projected Market Size: USD 65.78 billion
- CAGR (2025-2030): 12.6%
Proteomics Market Trends & Insights:
- By product, the spectroscopy segment held 44.1% of the market in 2024.
- By reagent, the immunoassay reagents segment held 26.4% of the overall market in 2024.
- North America accounted for a 38.8% revenue share in 2024.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731
The growth of the global proteomics market is attributed to several key factors, including rising life-science R&D funding, expanding public-private research programs, and strong momentum in translational and clinical proteomics.
The global proteomics market is rapidly maturing. Work in proteomics has been made possible by the powerful combination of high-throughput mass spectrometry and standardized, automation-friendly workflows. Next-generation proteomics platforms and stronger analytics are researchers' major tools for transitioning from exploratory studies to scalable, repeatable protein profiling. Meanwhile, data analysis, which is cloud-ready and AI-enabled, is facilitating faster and more consistent interpretation of results in large studies.
By technique, the spectroscopy segment held the largest market share in 2024.
Spectroscopy accounted for the largest share of the proteomics market in 2024. The dominance of spectroscopy in the global proteomics market is driven by its strong accuracy and sensitivity for protein detection and quantification. It enables reliable profiling even in complex samples, which makes it a preferred choice across high-throughput research workflows. Spectroscopy-based systems also support deeper biological interpretation through robust protein identification and quantification methods. The spectroscopy sub-market is segmented into mass spectroscopy, NMR spectroscopy, and CD spectroscopy.
Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=731
By application, the clinical diagnostics segment is expected to be the fastest-growing application.
The market is divided into clinical diagnostics, drug discovery and development, and other applications. Of these, clinical diagnostics held the largest share in the market in 2024. This is due to the rising use of proteomics in precision medicine and personalized healthcare across major global markets. Providers are focused beyond genes and adding protein-level signatures to improve clinical decisions. Demand is growing for proteomics tools that can identify and validate biomarkers for diseases with strong reproducibility.
North America accounted for the largest regional share in the global proteomics market in 2024.
North America represents the largest regional market for proteomics. The large share is supported by the strong presence of biotechnology and pharmaceutical companies, along with sustained R&D spending across discovery and translational programs. The region also benefits from a dense concentration of leading mass spectrometry vendors, proteomics reagent suppliers, and specialist service providers, which keeps adoption high and workflows well supported.
Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=731
Top Companies in Proteomics Market:
The Top Companies in Proteomics Market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Revvity (US), Illumina Inc. (US), and Promega Corporation (US), among others.
Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting
Related Reports:
Genotyping Assay Market - Global Forecast to 2029
Mass Spectrometry Market - Global Forecast to 2030
Drug Discovery Services Market - Global Forecast to 2030
Chromatography Accessories & Consumables Market - Global Forecast to 2030
Esoteric Testing Market - Global Forecast to 2029
About MarketsandMarkets
MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/proteomics-market-worth-65-78-billion-by-2030--marketsandmarkets-302671106.html
